Nitrong (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitrong, is a nitrate vasodilator presented as a transdermal patch for transdermal use. It provides continuous nitric oxide release to relieve chest pain associated with angina pectoris and is indicated for prophylaxis of angina, treatment of acute attacks, and management of chronic stable angina in adult patients.

GNH USA supplies Nitrong as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics for EU‑origin medicines.

Nitrong (glyceryl trinitrate) is used in the cardiovascular therapeutic area to manage angina related conditions. - Prophylaxis of angina pectoris: reduces frequency of chest pain episodes in patients with chronic stable angina. - Treatment of acute angina attacks: provides rapid relief of chest pain during an angina episode. - Management of chronic stable angina: maintains vasodilation to improve exercise tolerance in long‑term angina therapy.

Glyceryl trinitrate may cause a range of adverse reactions, most of which are related to its vasodilatory action. Common Side Effects: - Headache: transient throbbing headache due to cerebral vasodilation. - Flushing: warmth and redness of the skin, especially on the face. - Dizziness: light‑headed sensation, often on standing. Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall that can cause fainting. - Reflex tachycardia: rapid heart rate triggered by sudden vasodilation. - Methemoglobinemia: rare blood disorder reducing oxygen delivery.

When prescribing Nitrong, clinicians should consider several safety measures to minimize risks and ensure optimal therapy. - Assess cardiovascular status: evaluate blood pressure and heart rate before initiating therapy. - Avoid concurrent nitrate therapy: do not combine with other nitrate-containing medications to prevent additive hypotension. - Limit exposure to phosphodiesterase‑5 inhibitors: contraindicated with drugs such as sildenafil due to risk of severe hypotension. - Monitor for tolerance: assess for reduced efficacy over time and adjust therapy accordingly. - Educate patients on patch removal: advise proper site rotation and removal technique to avoid skin irritation. - Store at room temperature: keep patches below 25°C in original packaging, protected from moisture and light.

Glyceryl trinitrate interacts with several drug classes; awareness of these interactions helps prevent adverse events. Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors: concurrent use can cause profound hypotension. - Other nitrates or nitrites: additive vasodilatory effect may lead to severe blood pressure drop. - Antihypertensive agents: may enhance hypotensive response, requiring dose adjustment. Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia, necessitating careful blood pressure monitoring. - Diuretics: combined effect on blood pressure may require observation. - Alcohol: can potentiate vasodilatory effects, increasing dizziness risk.